Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Erectile Dysfunction

  Free Subscription


Articles published in J Urol

Retrieve available abstracts of 107 articles:
HTML format
Text format



Single Articles


    July 2019
  1. SEFTEL AD
    Re: Sub-External Oblique Placement of Inflatable Penile Prosthesis Reservoirs-Initial Experience.
    J Urol. 2019;202:14.
    PubMed     Text format    


    June 2019
  2. SEFTEL AD
    Re: Endovascular Therapy for Erectile Dysfunction-Who Benefits Most? Insights from a Single-Center Experience.
    J Urol. 2019 Jun 20:10109701JU0000574452612637.
    PubMed     Text format    


  3. SEFTEL AD
    Re: Erectile Dysfunction Medications and Skin Cancer: An Analysis in US Veterans.
    J Urol. 2019 Jun 20:10109701JU00005744566888619.
    PubMed     Text format    


  4. SEFTEL AD
    Re: Impact of Pelvic Radiation Therapy on Inflatable Penile Prosthesis Reoperation Rates.
    J Urol. 2019;201:1036-1037.
    PubMed     Text format    


  5. MOREY AF
    Re: Penile Sensory Changes after Plaque Incision and Grafting Surgery for Peyronie's Disease.
    J Urol. 2019;201:1046-1047.
    PubMed     Text format    


    May 2019
  6. SEFTEL AD
    Re: Tighter Blood Pressure Control is Associated with Lower Incidence of Erectile Dysfunction in Hypertensive Men.
    J Urol. 2019 May 7:10109701JU000055962970617.
    PubMed     Text format    


  7. SEFTEL AD
    Re: Erectile Dysfunction is Highly Prevalent in Men with Newly Diagnosed Inflammatory Bowel Disease.
    J Urol. 2019 May 7:10109701JU00005596272487625.
    PubMed     Text format    


  8. SEFTEL AD
    Re: Chronic Administration of LIMK2 Inhibitors Alleviates Cavernosal Veno-Occlusive Dysfunction through Suppression of Cavernosal Fibrosis in a Rat Model of Erectile Dysfunction after Cavernosal Nerve Injury.
    J Urol. 2019 May 7:10109701JU0000559626477475.
    PubMed     Text format    


  9. SEFTEL AD
    Re: Updated Evidence of Association between Periodontal Disease and Incident Erectile Dysfunction.
    J Urol. 2019;201:841.
    PubMed     Text format    


  10. SEFTEL AD
    Re: Erectile Dysfunction Severity as a Predictor of Left Main and/or Three-Vessel Disease in Acute Coronary Syndrome Patients.
    J Urol. 2019;201:842-843.
    PubMed     Text format    


  11. SEFTEL AD
    Re: Penile Prosthesis Reservoir Removal: Surgical Description and Patient Outcomes.
    J Urol. 2019;201:842.
    PubMed     Text format    


  12. MOREY AF
    Re: Penoscrotal versus Minimally Invasive Infrapubic Approach for Inflatable Penile Prosthesis Placement: A Single-Center Matched-Pair Analysis.
    J Urol. 2019;201:852.
    PubMed     Text format    


    April 2019
  13. SEFTEL AD
    Re: Penile Sensory Changes after Plaque Incision and Grafting Surgery for Peyronie's Disease.
    J Urol. 2019;201:650.
    PubMed     Text format    


    March 2019
  14. ATALA A
    Re: Genetic Variation in the SIM1 Locus is Associated with Erectile Dysfunction.
    J Urol. 2019 Mar 13:101097JU0000000000000215. doi: 10.1097/JU.0000000000000215.
    PubMed     Text format    


  15. COWARD RM, Stetter C, Kunselman A, Trussell JC, et al
    Fertility-Related Quality of Life, Gonadal Function, and Erectile Dysfunction in Male Partners of Couples with Unexplained Infertility.
    J Urol. 2019 Mar 5:101097JU0000000000000205. doi: 10.1097/JU.0000000000000205.
    PubMed     Text format     Abstract available


  16. SEFTEL AD
    Re: Bibliometric Analysis of Erectile Dysfunction Publications in Urology and Sexual Medicine Journals.
    J Urol. 2019;201:425.
    PubMed     Text format    


  17. SEFTEL AD
    Re: Treatment for Erectile Dysfunction among Older Men in Northern Ireland.
    J Urol. 2019;201:424.
    PubMed     Text format    


  18. KAPLAN SA
    Re: Long-Term Dutasteride Therapy in Men with Benign Prostatic Hyperplasia Alters Glucose and Lipid Profiles and Increases Severity of Erectile Dysfunction.
    J Urol. 2019;201:416-417.
    PubMed     Text format    


  19. HERNANDEZ JC, Trost L, Kohler T, Ring J, et al
    Emerging Complications Following Alternative Reservoir Placement during Inflatable Penile Prosthesis Placement: A 5-Year Multi-Institutional Experience.
    J Urol. 2019;201:581-586.
    PubMed     Text format     Abstract available


    February 2019
  20. MOREY AF
    Re: Risk Stratification for Erectile Dysfunction after Pelvic Fracture Urethral Injuries.
    J Urol. 2019 Feb 15:10109701JU0000554199667014.
    PubMed     Text format    


  21. SEFTEL AD
    Re: A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Utility of Tacrolimus (FK506) for the Prevention of Erectile Dysfunction following Bilateral Nerve-Sparing Radical Prostatectomy.
    J Urol. 2019;201:212.
    PubMed     Text format    


  22. SEFTEL AD
    Re: Alcohol Intake and Risk of Erectile Dysfunction: .
    J Urol. 2019;201:212.
    PubMed     Text format    


  23. SEFTEL AD
    Re: The Risk of Erectile Dysfunction following Pelvic Angiographic Embolization in Pelvic Fracture Patients: .
    J Urol. 2019;201:211-212.
    PubMed     Text format    


  24. SEFTEL AD
    Re: The Masturbation Erection Index (MEI): .
    J Urol. 2019;201:210-211.
    PubMed     Text format    


    January 2019
  25. SEFTEL AD
    Re: Biomechanical Comparison of Inflatable Penile Implants: A Cadaveric Pilot Study.
    J Urol. 2019;201:15.
    PubMed     Text format    


  26. PATEL N, Golan R, Halpern JA, Sun T, et al
    A Contemporary Analysis of Dual Inflatable Penile Prosthesis and Artificial Urinary Sphincter Outcomes.
    J Urol. 2019;201:141-146.
    PubMed     Text format     Abstract available


    November 2018
  27. KAPLAN SA
    Re: Efficacy and Safety of a Fixed-Dose Combination Therapy of Tamsulosin and Tadalafil for Patients with Lower Urinary Tract Symptoms and Erectile Dysfunction: Results of a Randomized, Double-Blinded, Active-Controlled Trial.
    J Urol. 2018;200:918-921.
    PubMed     Text format    


    October 2018
  28. SEFTEL AD
    Re: Real-World Observational Results from a Database of 48 Million Men in the United States: Relationship of Cardiovascular Disease, Diabetes Mellitus and Depression with Age and Erectile Dysfunction.
    J Urol. 2018;200:680-682.
    PubMed     Text format    


    September 2018
  29. CHAPMAN DW, Cotter K, Johnsen NV, Patel S, et al
    Non-Transecting Techniques Reduce Sexual Dysfunction After Anastomotic Bulbar Urethroplasty: Results of a Multi-Institutional Comparative Analysis.
    J Urol. 2018 Sep 25. pii: S0022-5347(18)43945-6. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available


  30. SEFTEL AD
    Re: The Effect of Low-Intensity Extracorporeal Shockwave Therapy in an Obesity-Associated Erectile Dysfunction Rat Model.
    J Urol. 2018;200:482.
    PubMed     Text format    


  31. SEFTEL AD
    Re: Abnormal Brain Structure as a Potential Biomarker for Venous Erectile Dysfunction: Evidence from Multimodal MRI and Machine Learning.
    J Urol. 2018;200:481-482.
    PubMed     Text format    


  32. SEFTEL AD
    Re: Efficacy and Safety of Tadalafil 5 mg Once Daily for the Treatment of Erectile Dysfunction after Robot-Assisted Laparoscopic Radical Prostatectomy: A 2-Year Follow-up.
    J Urol. 2018;200:481.
    PubMed     Text format    


  33. SEFTEL AD
    Re: The Role of Neutrophil-to-Lymphocyte Ratio in Men with Erectile Dysfunction-Preliminary Findings of a Real-Life Cross-Sectional Study.
    J Urol. 2018;200:480-482.
    PubMed     Text format    


    July 2018
  34. LOPATEGUI DM, Balise RR, Bouzoubaa LA, Wilson SK, et al
    The Impact of Immediate Salvage Surgery on Corporeal Length Preservation in Patients Presenting with Penile Implant Infections.
    J Urol. 2018;200:171-177.
    PubMed     Text format     Abstract available


    June 2018
  35. SEFTEL AD
    Re: Efficacy and Safety of MED2005, a Topical Glyceryl Trinitrate Formulation, in the Treatment of Erectile Dysfunction: A Randomized Crossover Study.
    J Urol. 2018;199:1378-1380.
    PubMed     Text format    


    May 2018
  36. BURNETT AL, Nehra A, Breau RH, Culkin DJ, et al
    Erectile Dysfunction: AUA Guideline.
    J Urol. 2018 May 7. pii: S0022-5347(18)43100-X. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available


  37. BANDAK M, Lauritsen J, Johansen C, Kreiberg M, et al
    Sexual function in a nationwide cohort of 2260 testicular cancer survivors after 17 years follow-up.
    J Urol. 2018 May 3. pii: S0022-5347(18)43080-7. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available


  38. SEFTEL AD
    Re: Erectile Dysfunction and Quality of Life in Men Receiving Methadone or Buprenorphine Maintenance Treatment. A Cross-Sectional Multicentre Study.
    J Urol. 2018;199:1095-1097.
    PubMed     Text format    


    March 2018
  39. KOHLER TS
    Editorial Comment.
    J Urol. 2018;199:810-811.
    PubMed     Text format    


    February 2018
  40. KITREY ND, Vardi Y, Appel B, Shechter A, et al
    Low-intensity shockwave treatment for erectile dysfunction - how long does the effect last?
    J Urol. 2018 Feb 22. pii: S0022-5347(18)39376-5. doi: 10.1016/j.juro.2018.
    PubMed     Text format     Abstract available


  41. SEFTEL AD
    Re: Quality of Erections by Age Group in Men with Erectile Dysfunction.
    J Urol. 2018;199:328.
    PubMed     Text format    


  42. SEFTEL AD
    Re: Prognostic Value of Exercise Capacity among Men Undergoing Pharmacologic Treatment for Erectile Dysfunction: The FIT Project.
    J Urol. 2018;199:327-329.
    PubMed     Text format    


    January 2018
  43. SEFTEL AD
    Re: Long-Term Outcomes of AMS Spectra(R) Penile Prosthesis Implantation and Satisfaction Rates.
    J Urol. 2018;199:15-16.
    PubMed     Text format    


  44. SEFTEL AD
    Re: Inflatable Penile Prosthesis as Tissue Expander: What is the Evidence?
    J Urol. 2018;199:15.
    PubMed     Text format    


    December 2017
  45. SEFTEL AD
    Re: Factors Associated with Erectile Dysfunction and the Peyronie's Disease Questionnaire in Patients with Peyronie Disease.
    J Urol. 2017;198:1193-1194.
    PubMed     Text format    


  46. SEFTEL AD
    Re: Does any Association Exist between Chronic Obstructive Pulmonary Disease and Erectile Dysfunction? The DECODED Study.
    J Urol. 2017;198:1192-1194.
    PubMed     Text format    


  47. MOREY AF
    Re: The Effect of Urethral Transection on Erectile Function after Anterior Urethroplasty.
    J Urol. 2017;198:1202.
    PubMed     Text format    


    November 2017
  48. SEFTEL AD
    Re: Low-Intensity Shockwave Therapy Improves Hemodynamic Parameters in Patients with Vasculogenic Erectile Dysfunction: A Triplex Ultrasonography-Based Sham-Controlled Trial.
    J Urol. 2017;198:964.
    PubMed     Text format    


  49. SEFTEL AD
    Re: Male Sexual Function in New Zealand: A Population-Based Cross-Sectional Survey of the Prevalence of Erectile Dysfunction in Men Aged 40-70 Years.
    J Urol. 2017;198:963-965.
    PubMed     Text format    


    September 2017
  50. KAPLAN SA
    Re: Impact of Combination Therapy 5-Alpha Reductase Inhibitors (5-ARI) plus Alpha-Blockers (AB) on Erectile Dysfunction and Decrease of Libido in Patients with LUTS/BPH: A Systematic Review with Meta-Analysis.
    J Urol. 2017;198:457-458.
    PubMed     Text format    


  51. KAPLAN SA
    Re: A Prospective Longitudinal Survey of Erectile Function Status in Symptomatic Benign Prostatic Hyperplasia Patients Treated with Dutasteride.
    J Urol. 2017;198:459.
    PubMed     Text format    


    August 2017
  52. SEFTEL AD
    Re: Combination of Mesenchymal Stem Cell Injection with Icariin for the Treatment of Diabetes-Associated Erectile Dysfunction.
    J Urol. 2017;198:238.
    PubMed     Text format    


  53. SEFTEL AD
    Re: Subclinical Vascular Disease and Subsequent Erectile Dysfunction: The Multiethnic Study of Atherosclerosis (MESA).
    J Urol. 2017;198:236-237.
    PubMed     Text format    


  54. SEFTEL AD
    Re: Association between Treatment for Erectile Dysfunction and Death or Cardiovascular Outcomes after Myocardial Infarction.
    J Urol. 2017;198:236-238.
    PubMed     Text format    


  55. SEFTEL AD
    Re: Relationship between Age and Erectile Dysfunction Diagnosis or Treatment Using Real-World Observational Data in the USA.
    J Urol. 2017;198:235-236.
    PubMed     Text format    


  56. SEFTEL AD
    Re: Validity of Premature Ejaculation Diagnostic Tool and its Association with International Index of Erectile Function-15 in Chinese Men with Evidence-Based-Defined Premature Ejaculation.
    J Urol. 2017;198:237-238.
    PubMed     Text format    


    July 2017
  57. YANG L, Kibel AS, Colditz GA, Pakpahan R, et al
    Caution with Use of the Expanded Prostate Cancer Index Composite-50 Urinary Bother Scale: How Voiding Dysfunction Modifies Its Performance.
    J Urol. 2017 Jul 17. pii: S0022-5347(17)77147-9. doi: 10.1016/j.juro.2017.
    PubMed     Text format     Abstract available


    June 2017
  58. SEFTEL AD
    Re: Self-Reported Sitting Time and Prevalence of Erectile Dysfunction in Japanese Patients with Type 2 Diabetes Mellitus: The Dogo Study.
    J Urol. 2017;197:1534.
    PubMed     Text format    


  59. SEFTEL AD
    Re: Skin Autofluorescence (a Marker for Advanced Glycation End Products) and Erectile Dysfunction in Diabetes.
    J Urol. 2017;197:1533-1535.
    PubMed     Text format    


  60. SEFTEL AD
    Re: Rasch Analysis of the Premature Ejaculation Diagnostic Tool (PEDT) and the International Index of Erectile Function (IIEF) in an Iranian Sample of Prostate Cancer Patients.
    J Urol. 2017;197:1534-1535.
    PubMed     Text format    


    May 2017
  61. SEFTEL AD
    Re: Prevalence of Use of Erectile Dysfunction Medication by Dutch Military Personnel between 2003 and 2012.
    J Urol. 2017;197:1333.
    PubMed     Text format    


    March 2017
  62. SEFTEL AD
    Re: Mirabegron Causes Relaxation of Human and Rat Corpus Cavernosum: Could it be a Potential Therapy for Erectile Dysfunction?
    J Urol. 2017;197.
    PubMed     Text format    


    February 2017
  63. ATALA A
    Re: Treatment of Diabetes Mellitus-Induced Erectile Dysfunction Using Endothelial Progenitor Cells Genetically Modified with Human Telomerase Reverse Transcriptase.
    J Urol. 2017;197:494.
    PubMed     Text format    


    January 2017
  64. KAPLAN SA
    Re: Finasteride, Not Tamsulosin, Increases Severity of Erectile Dysfunction and Decreases Testosterone Levels in Men with Benign Prostatic Hyperplasia.
    J Urol. 2017;197:221-222.
    PubMed     Text format    


    December 2016
  65. WALSH PC, Donker PJ
    Impotence Following Radical Prostatectomy: Insight into Etiology and Prevention.
    J Urol. 2016 Dec 21. pii: S0022-5347(16)31658-5. doi: 10.1016/j.juro.2016.
    PubMed     Text format     Abstract available


  66. BURNETT AL
    Impotence after Radical Prostatectomy.
    J Urol. 2016 Dec 20. pii: S0022-5347(16)31721-9. doi: 10.1016/j.juro.2016.
    PubMed     Text format    


  67. NANGIA AK
    Testosterone Replacement Should be Given to Men with Erectile Dysfunction: Con.
    J Urol. 2016 Dec 17. pii: S0022-5347(16)31775-X. doi: 10.1016/j.juro.2016.
    PubMed     Text format    


  68. CLAVIJO RI, Ramasamy R
    Testosterone Replacement Should be Given to Men with Erectile Dysfunction: Pro.
    J Urol. 2016 Dec 17. pii: S0022-5347(16)31774-8. doi: 10.1016/j.juro.2016.
    PubMed     Text format    


    November 2016
  69. SEFTEL AD
    Re: Vasculogenesis and Diabetic Erectile Dysfunction: How Relevant is Glycemic Control?
    J Urol. 2016;196:1588.
    PubMed     Text format    


  70. SEFTEL AD
    Re: The Effects of Adipose-Derived Stem Cells in a Rat Model of Tobacco-Associated Erectile Dysfunction.
    J Urol. 2016;196:1587-1588.
    PubMed     Text format    


    October 2016
  71. SEFTEL AD
    Re: Recovery of Baseline Erectile Function in Men following Radical Prostatectomy for High-Risk Prostate Cancer: A Prospective Analysis Using Validated Measures.
    J Urol. 2016;196:1228-30.
    PubMed     Text format    


    September 2016
  72. BOZORGMEHRI S, Fink HA, Parimi N, Canales B, et al
    Association of Sleep-Disordered Breathing With Erectile Dysfunction In Community-Dwelling Older Men.
    J Urol. 2016 Sep 30. pii: S0022-5347(16)31408-2. doi: 10.1016/j.juro.2016.
    PubMed     Text format     Abstract available


  73. SEFTEL AD
    Re: Vascular and Chronological Age in Men with Erectile Dysfunction: A Longitudinal Study.
    J Urol. 2016;196:857-8.
    PubMed     Text format    


  74. SEFTEL AD
    Re: A Nationwide Population-Based Cohort Study of Migraine and Organic-Psychogenic Erectile Dysfunction.
    J Urol. 2016;196:857.
    PubMed     Text format    


    August 2016
  75. SEFTEL AD
    Re: Six Months of Daily Treatment with Vardenafil Improves Parameters of Endothelial Inflammation and of Hypogonadism in Male Patients with Type 2 Diabetes and Erectile Dysfunction: A Randomized, Double-Blind, Prospective Trial.
    J Urol. 2016;196:518-9.
    PubMed     Text format    


  76. SEFTEL AD
    Re: Tadalafil 5 mg Once Daily for the Treatment of Erectile Dysfunction during a 6-Month Observational Study (EDATE): Impact of Patient Characteristics and Comorbidities.
    J Urol. 2016;196:515-6.
    PubMed     Text format    


  77. MOREY AF
    Re: The Vascular and Neurogenic Factors Associated with Erectile Dysfunction in Patients after Pelvic Fractures.
    J Urol. 2016;196:462-3.
    PubMed     Text format    


    July 2016
  78. KAPLAN SA, Griebling TL
    Re: The Co-Occurring Syndrome-Coexisting Erectile Dysfunction and Benign Prostatic Hyperplasia and Their Clinical Correlates in Aging Men: Results from the National Health and Nutrition Examination Survey.
    J Urol. 2016;196:190-1.
    PubMed     Text format    


    June 2016
  79. SEFTEL AD
    Re: Effect of Levitra on Sustenance of Erection (EROS): An Open-Label, Prospective, Multicenter, Single-Arm Study to Investigate Erection Duration Measured by Stopwatch with Flexible Dose Vardenafil Administered for 8 Weeks in Subjects with Erectile D
    J Urol. 2016;195:1854-6.
    PubMed     Text format    


    May 2016
  80. MOREY AF
    Re: Penile Prosthesis First and Replacement Surgeries: Analysis of Patient and Partner Satisfaction.
    J Urol. 2016;195:1510.
    PubMed     Text format    


  81. MOREY AF
    Re: The Prevention and Management of Noninfectious Complications of Penile Implants.
    J Urol. 2016;195:1509-10.
    PubMed     Text format    


  82. KITREY ND, Gruenwald I, Appel B, Shechter A, et al
    Penile Low Intensity Shock Wave Treatment is Able to Shift PDE5i Nonresponders to Responders: A Double-Blind, Sham Controlled Study.
    J Urol. 2016;195:1550-5.
    PubMed     Text format     Abstract available


    April 2016
  83. WHITSON JM, Murray KS, Thrasher JB
    Prostate Biopsy is Associated with an Increased Risk of Erectile Dysfunction.
    J Urol. 2016 Apr 8. pii: S0022-5347(16)30136-7. doi: 10.1016/j.juro.2016.
    PubMed     Text format    


  84. JAMNAGERWALLA J, Howard LE, Vidal AC, Moreira DM, et al
    The Association Between Phosphodiesterase Type-5 Inhibitors and Prostate Cancer: Results from the REDUCE Study.
    J Urol. 2016 Apr 5. pii: S0022-5347(16)30127-6. doi: 10.1016/j.juro.2016.
    PubMed     Text format     Abstract available


  85. SEFTEL AD
    Re: Intraoperative Decision-Making for Precise Penile Straightening during Inflatable Penile Prosthesis Surgery.
    J Urol. 2016;195.
    PubMed     Text format    


  86. SEFTEL AD
    Re: The Importance of Psychosexual Counselling in the Re-Establishment of Organic and Erotic Functions after Penile Prosthesis Implantation.
    J Urol. 2016;195.
    PubMed     Text format    


    March 2016
  87. SEFTEL AD
    Re: Erectile Dysfunction in 1050 Men following Extended (18 Cores) vs Saturation (28 Cores) vs Saturation plus MRI-Targeted Prostate Biopsy (32 Cores).
    J Urol. 2016;195:714-5.
    PubMed     Text format    


  88. SEFTEL AD
    Re: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
    J Urol. 2016;195:713-5.
    PubMed     Text format    


  89. SEFTEL AD
    Re: Unexpected Long-Term Improvements in Urinary and Erectile Function in a Large Cohort of Men with Self-Reported Outcomes following Radical Prostatectomy.
    J Urol. 2016;195:713-4.
    PubMed     Text format    


    February 2016
  90. CADEDDU JA
    Re: Urinary Incontinence and Erectile Dysfunction after Robotic versus Open Radical Prostatectomy: A Prospective, Controlled, Nonrandomised Trial.
    J Urol. 2016;195:354.
    PubMed     Text format    


  91. MOREY AF
    Re: Prospective Evaluation of Postoperative Penile Rehabilitation: Penile Length/Girth Maintenance 1 Year following Coloplast Titan Inflatable Penile Prosthesis.
    J Urol. 2016;195:444.
    PubMed     Text format    


  92. EBERT AK
    Editorial Comment.
    J Urol. 2016;195:470.
    PubMed     Text format    


  93. RUBENWOLF P, Thomas C, Thuroff JW, Stein R, et al
    Sexual Function, Social Integration and Paternity of Males with Classic Bladder Exstrophy following Urinary Diversion.
    J Urol. 2016;195:465-70.
    PubMed     Text format     Abstract available


  94. HENRY GD, Karpman E, Brant W, Christine B, et al
    The Who, How and What of Real-World Penile Implantation in 2015: The PROPPER Registry Baseline Data.
    J Urol. 2016;195:427-33.
    PubMed     Text format     Abstract available


    January 2016
  95. LOEB S, Lambe M, Stattin P
    Re: Editorial Comment on Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma: D. F. Penson J Urol 2015;194:1710-1711.
    J Urol. 2016 Jan 16. pii: S0022-5347(15)05310-0. doi: 10.1016/j.juro.2015.
    PubMed     Text format    


  96. SEFTEL AD
    Re: Finasteride, Not Tamsulosin, Increases Severity of Erectile Dysfunction and Decreases Testosterone Levels in Men with Benign Prostatic Hyperplasia.
    J Urol. 2016;195:139.
    PubMed     Text format    


    December 2015
  97. PENSON DF
    Re: Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
    J Urol. 2015;194:1710-1711.
    PubMed     Text format    


  98. SEFTEL AD
    Re: Increased Risk of Dementia in Patients with Erectile Dysfunction: A Population-Based, Propensity Score-Matched, Longitudinal Follow-up Study.
    J Urol. 2015;194:1708-1709.
    PubMed     Text format    


  99. SEFTEL AD
    Re: Sex Offenders Seeking Treatment for Sexual Dysfunction--Ethics, Medicine, and the Law.
    J Urol. 2015;194:1708.
    PubMed     Text format    


    November 2015
  100. PEYTON CC, Colaco MA, Kovell RC, Kim JH, et al
    Erectile Dysfunction is Predictive of Endothelial Dysfunction in a Well-Visit Population.
    J Urol. 2015 Nov 22. pii: S0022-5347(15)05259-3. doi: 10.1016/j.juro.2015.
    PubMed     Text format     Abstract available


  101. SEFTEL AD
    Re: Evaluation of Clinical Efficacy, Safety and Patient Satisfaction Rate after Low-Intensity Extracorporeal Shockwave Therapy for the Treatment of Male Erectile Dysfunction: An Australian First Open-Label Single-Arm Prospective Clinical Trial.
    J Urol. 2015;194:1364.
    PubMed     Text format    


  102. SILVA CN, Nunes KP, Torres FS, Cassoli JS, et al
    PnPP-19, a Synthetic and Nontoxic Peptide Designed from a Phoneutria nigriventer Toxin, Potentiates Erectile Function via NO/cGMP.
    J Urol. 2015;194:1481-90.
    PubMed     Text format     Abstract available


    October 2015
  103. LIN H, Dhanani N, Tseng H, Souza GR, et al
    Nanoparticle Improved Stem Cell Therapy for Erectile Dysfunction in a Rat Model of Cavernous Nerve Injury.
    J Urol. 2015 Oct 28. pii: S0022-5347(15)05149-6. doi: 10.1016/j.juro.2015.
    PubMed     Text format     Abstract available


    July 2015
  104. SEFTEL AD
    Re: A Randomised Controlled Trial of a Couples-Based Sexuality Intervention for Men with Localised Prostate Cancer and their Female Partners.
    J Urol. 2015;194:167-8.
    PubMed     Text format    


    May 2015
  105. ZILLI T, Miralbell R
    Re: Prophylactic Sildenafil Citrate Improves Select Aspects of Sexual Function in Men Treated with Radiotherapy for Prostate Cancer: M. J. Zelefsky, D. Shasha, R. D. Branco, M. Kollmeier, R. E. Baser, X. Pei, R. Ennis, R. Stock, N. Bar-Chama and J. P.
    J Urol. 2015 May 6. pii: S0022-5347(15)03228-0. doi: 10.1016/j.juro.2014.
    PubMed     Text format    


  106. KAPLAN SA
    Re: Patient-reported sexual outcomes after holmium laser enucleation of the prostate: a 3-year follow-up study.
    J Urol. 2015;193:1604-5.
    PubMed     Text format    


    April 2015
  107. SEFTEL AD
    Re: Effects of holmium laser enucleation of the prostate on sexual function.
    J Urol. 2015;193:1326-7.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Erectile Dysfunction is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: